Luca Benatti, Director at Quince Therapeutics, Inc. (QNCX), sold 50,000 shares at $3.47 ($174K) on 2025-12-26, disclosed to the SEC on 2025-12-29.
Open-market sale of $174k QNCX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |